申请人:The McLean Hospital Corporation
公开号:US10081600B2
公开(公告)日:2018-09-25
The invention features 2-alkoxy-11-hydroxyaporphine derivatives that selectively bind D2high receptors. The compounds are useful for imaging D2high receptors and for the treatment of diseases, such as Parkinson's disease, sexual dysfunction, and depressive disorders.
本发明具有选择性结合 D2high 受体的 2-烷氧基-11-羟基吗啡衍生物。这些化合物可用于 D2high 受体成像和疾病治疗,如帕金森病、性功能障碍和抑郁症。